why choose us

First received: October 15, 2024

Clinical Trial: Smart MDI Study (CIP343)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus, Type 1

Study Type: INTERVENTIONAL


Official Title: Smart MDI Randomized Controlled Trial in Subjects With Type 1 Diabetes (Smart MDI Study)

Brief Summary: The purpose of the study is to evaluate the effectiveness of the Smart MDI system with InPen™ and Simplera™ in comparison with Multiple Daily Injection (MDI) therapy with intermittent scanning or real-time Continuous Glucose Monitoring (isCGM/CGM) over 6 months duration in people with type 1 diabetes to support the market access and therapy adoption of the Smart MDI system.

Read more